Related Experiment Video
Updated: Jul 13, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Obesity and reproduction: impact and interventions
Scott M Nelson1, Richard Fleming
1Reproductive and Maternal Medicine, University of Glasgow, Glasgow, UK. s.nelson@clinmed.gla.ac.uk
Current Opinion in Obstetrics & Gynecology
|July 13, 2007
Summary
Obesity negatively impacts female fertility, increasing risks during pregnancy and reducing treatment efficacy. Weight loss through lifestyle changes or medical interventions can improve reproductive outcomes and maternal health.
Area of Science:
- Reproductive Endocrinology
- Obesity Medicine
- Maternal-Fetal Medicine
Background:
- Rising prevalence of obesity in women of reproductive age.
- Visceral obesity linked to metabolic disturbances and reduced fecundity.
- Obesity's impact on fertility, pregnancy, and long-term health.
Purpose of the Study:
- To evaluate the effects of obesity on human reproduction.
- To assess the role of interventions in mitigating these effects.
- To inform clinical practice regarding fertility and pregnancy in obese women.
Main Methods:
- Review of current literature on obesity and reproduction.
- Analysis of data on fertility treatment outcomes.
- Examination of pregnancy risks and complications associated with obesity.
Main Results:
- Obesity reduces fertility treatment efficacy, though not profoundly.
- Increased perinatal and maternal risks during pregnancy are associated with obesity.
- Lifestyle modification, pharmacotherapy, and bariatric surgery can lead to significant weight loss and improved outcomes.
Conclusions:
- Obesity poses significant risks to female reproduction and pregnancy.
- Weight loss interventions are crucial for improving reproductive health and reducing complications.
- Fertility centers should counsel obese patients on risks and implement tailored strategies.
More Related Videos
13:09Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
Published on: April 4, 2012
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
01:30Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...